Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape

Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape

Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape 1707 2560 Metabolism & Cancer
Metabolic plasticity in metastatic colorectal cancer in response to Palbociclib
Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.